Marco Cattaneo

Overview

Best Publications

• ISTH interim guidance on recognition and management of coagulopathy in COVID-19.

  Jecko Thachil;Ning Tang;Satoshi Gando;Anna Falanga

  2108
  Citations

• Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

  Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

  1373
  Citations

• Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.

  Piera Angelica Merlini;Kenneth A. Bauer;Luigi Oltrona;Diego Ardissino

  862
  Citations

• Hyperhomocysteinemia, atherosclerosis and thrombosis.

  Marco Cattaneo

  632
  Citations

• Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance

  Marco Cattaneo

  584
  Citations

• Recommendations for the standardization of light transmission aggregometry : a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH

  M. Cattaneo;C. Cerletti;P. Harrison;C. P M Hayward

  582
  Citations

• Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls

  Joseph Emmerich;Frits R. Rosendaal;Marco Cattaneo;Maurizio Margaglione

  489
  Citations

• Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism

  Marco Cattaneo;Maria Luisa Monzani;Ida Martinelli;Cristina Rosario Falcon

  470
  Citations

• Aspirin resistance: position paper of the Working Group on Aspirin Resistance

  Allan D. Michelson;M. Cattaneo;J. W. Eikelboom;P. Gurbel

  454
  Citations

• Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function

  C. P. M. Hayward;P. Harrison;M. Cattaneo;T. L. Ortel

  369
  Citations

• High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

  Cristina R. Falcon;Marco Cattaneo;Daniela Panzeri;Ida Martinelli

  357
  Citations

• IMPROVEMENT IN THE HAEMOSTATIC DEFECT OF URAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN

  Marco Moia;Laura Vizzotto;Marco Cattaneo;Pier Mannuccio Mannucci

  344
  Citations

• Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?

  Marco Cattaneo;Elena M. Bertinato;Simone Birocchi;Carolina Brizio

  339
  Citations

• Adenosine-Mediated Effects of Ticagrelor: Evidence and Potential Clinical Relevance

  Marco Cattaneo;Rainer Schulz;Sven Nylander

  338
  Citations

• Hyperhomocysteinemia in cerebral vein thrombosis

  Ida Martinelli;Tullia Battaglioli;Paola Pedotti;Marco Cattaneo

  331
  Citations

• Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial

  Martin den Heijer;Huub P. J. Willems;Henk J. Blom;Wim B. J. Gerrits

  320
  Citations

• New P2Y(12) inhibitors.

  Marco Cattaneo

  285
  Citations

• A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo.

  Béatrice Hechler;Nadège Lenain;Patrizia Marchese;Catherine Vial

  275
  Citations

• Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection.

  M. Cattaneo

  271
  Citations

• Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time

  Pier Mannuccio Mannucci;Vicente Vicente;Luciana Vianello;Marco Cattaneo

  268
  Citations